Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEW DAY Study of ILUVIEN in Diabetic Macular Edema
NCT04469595Phase 4Active, not recruiting
- Sponsor
- Alimera Sciences
- Start
- Aug 2020
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluocinolone acetonide intravitreal implant in diabetic macular edema (DME), sponsored by Alimera Sciences. Started Aug 2020; status: active, not recruiting.
02
Drugs
fluocinolone acetonide intravitreal implant
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04469595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04469595.